Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Myomectomy vs Uterine Artery Embolization vs GnRh Antagonist for AUB-L

NCT04856306 is registered in ClinicalTrials.gov with Medstar Health Research Institute as lead sponsor.

NCT NCT04856306
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04856306 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Myomectomy vs Uterine Artery Embolization vs GnRh Antagonist for AUB-L
Lead sponsor
Medstar Health Research Institute
Phase
Observational
Overall status
Unknown status
Start date
April 12, 2021
Completion date
August 30, 2025
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fibroid uterus, heavy menstrual bleeding